Target intelligence / Profile preview

Bacterial transcription-translation machinery (BTTM)

Target
BTTM
Molecular classification
Enzyme complex, Ribonucleoprotein complex, RNA polymerase, Ribosome
01

Overview

The bacterial transcription-translation machinery is the integrated system of enzymes and ribonucleoproteins responsible for converting genetic information into functional proteins. This machinery primarily consists of DNA-dependent RNA polymerase, which catalyzes the synthesis of mRNA, and the 70S ribosome (comprising 30S and 50S subunits), which facilitates the translation of mRNA into polypeptide chains. In the context of plasmids, these extrachromosomal elements hijack the host's machinery to express genes that often confer selective advantages, such as antibiotic resistance or virulence factors. Because this machinery is evolutionarily distinct from eukaryotic systems, it serves as a primary target for a wide range of antibiotics. Drugs like rifamycins target the transcription phase by binding to RNA polymerase, while macrolides, tetracyclines, and aminoglycosides target various stages of the translation process on the ribosome. Understanding the interaction between plasmids and the host machinery is critical for addressing the spread of mobile genetic elements that drive global antimicrobial resistance.

Other names
Bacterial gene expression apparatusProkaryotic transcription-translation systemBacterial protein synthesis machineryHost-plasmid expression system
02

Mechanism of action

Inhibition of DNA-dependent RNA polymerase to block transcription or binding to the 30S or 50S ribosomal subunits to inhibit protein translation.

03

Biological functions

TranscriptionTranslationProtein synthesisGene expressionPlasmid replication and maintenance
04

Disease associations

Bacterial infectionAntimicrobial resistanceSepsis
05

Safety considerations

Disruption of host microbiomeDevelopment of multidrug resistanceOtotoxicity and nephrotoxicity (specifically with aminoglycosides)Potential cross-reactivity with mitochondrial ribosomes
06

Interacting drugs

Rifampicin

6 more in the full profile.

07

Biomarkers

Bacterial 16S rRNA levelsPlasmid copy numberMinimum Inhibitory Concentration (MIC)RNA polymerase beta subunit (rpoB) mutations

Beyond the preview

Go deeper on Bacterial transcription-translation machinery (BTTM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial transcription-translation machinery (BTTM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call